Cell Culture Technology– category –
-
Chivanta Analysis: Allogeneic CAR-T Surpasses Autologous in Scalable Manufacturing and Immediate Availability, Spotlighting Fate Therapeutics’ iPSC Platform
Chivanta USA Overview Chivanta's analysis indicates allogeneic CAR-T therapies hold significant advantages over autologous CAR-T, particularly in scalable manufacturing, immediate availability, and product consistency. Companies like All... -
Drug Discovery News Analyzes Viral Vector Manufacturing Scale-Up Challenges for Gene Therapies, Highlighting AAV Production Bottlenecks
Drug Discovery News USA Overview Drug Discovery News focuses on the significant scale-up challenges in viral vector manufacturing for gene therapies, particularly emphasizing bottlenecks in adeno-associated virus (AAV) production. The ar... -
Separation Science Reports AI-Assisted Protein A Chromatography Optimization for mAb Purification: Real-Time Predictive Control Enhances Yield and Purity
Separation Science USA Overview Separation Science reports on a breakthrough application of AI and machine learning (ML) in optimizing Protein A chromatography for monoclonal antibody (mAb) purification. AI models accurately predict dyna... -
Select Science Introduces Gri3D® Hydrogel Microcavity Plates: Achieving High Reproducibility and Scalability in Standardized Organoid Culture
Select Science UK Overview Select Science has highlighted the Gri3D® Hydrogel Microcavity Plates, which dramatically improve the reproducibility and scalability of organoid culture. This system utilizes PEG-based hydrogel microcavities t... -
Singapore First Nation to Approve Commercial Sale of Eat Just’s Cultivated Chicken, Marking Historic Milestone Despite High Production Costs
Space Daily Singapore Overview In December 2020, Singapore became the first country globally to approve the commercial sale of "Good Meat" chicken, cultivated from cells by San Francisco-based Eat Just in bioreactors. This landmark decis... -
Lonza Boosts Biologics Manufacturing with Dual Expansion: Swiss ADC Capacity and Enhanced US Biopharma Partnership with N-1 Perfusion Technology
Industry Week USA Overview Lonza has significantly strengthened its biopharmaceutical manufacturing capabilities through a massive expansion of its Antibody-Drug Conjugate (ADC) production capacity in Switzerland and an extended long-ter... -
Vector BioMed’s LENTIVERSE™ Platform Accelerates CAR-T Manufacturing from Gene Sequence to Clinic-Ready in Under 12 Months
Vector BioMed USA Overview Vector BioMed has launched LENTIVERSE™, a lentiviral vector platform designed to dramatically accelerate CAR-T cell therapy manufacturing, aiming for completion from gene sequence to clinic-ready in less than 1... -
Separation Science Details AI and Machine Learning’s Role in Real-Time Process Monitoring and Predictive Control for Downstream Bioprocessing
Separation Science USA Overview Separation Science elaborates on how AI and machine learning are enabling real-time process monitoring and predictive control in downstream bioprocessing, particularly in chromatography purification. The a... -
Drug Discovery News Identifies Critical Bottlenecks in Cell & Gene Therapy Manufacturing: Low Viral Vector Purification Yields and Plasmid DNA Supply Shortages
Drug Discovery News USA Overview Drug Discovery News highlights severe bottlenecks in cell and gene therapy (CGT) manufacturing, specifically in viral vector production. Low downstream purification yields for adeno-associated virus (AAV)... -
Cellistic Launches Integrated CDMO Services for iPSC-Derived Allogeneic Cell Therapies, Streamlining Development to GMP Manufacturing
Cellistic USA Overview Cellistic has introduced comprehensive CDMO services for iPSC-derived cell therapy manufacturing, covering development through GMP production. Their bioreactor-based Cellistic Echo platforms are engineered to ensur...
